{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T01:22:16Z","timestamp":1783041736351,"version":"3.54.6"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7254385"],"award-info":[{"award-number":["7254385"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32571109"],"award-info":[{"award-number":["32571109"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271869"],"award-info":[{"award-number":["82271869"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ijbiomac.2026.152523","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T06:33:15Z","timestamp":1778567595000},"page":"152523","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Nanoadjuvant and recombinant hemagglutinin protein-based mucosal influenza nanovaccine confers protection against lethal viral challenge in mice"],"prefix":"10.1016","volume":"367","author":[{"given":"Yongru","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanglin","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuying","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifang","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoyang","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinming","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penghui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2026.152523_bb0005","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/s41586-024-08054-z","article-title":"The global H5N1 influenza panzootic in mammals","volume":"637","author":"Peacock","year":"2025","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152523_bb0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41572-018-0002-y","article-title":"Influenza","volume":"4","author":"Krammer","year":"2018","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"51","key":"10.1016\/j.ijbiomac.2026.152523_bb0015","article-title":"Global production capacity of seasonal and pandemic influenza vaccines in 2023","volume":"2","author":"Taaffe","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.ijbiomac.2026.152523_bb0020","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.coi.2018.04.010","article-title":"Improving influenza vaccines: challenges to effective implementation","volume":"53","author":"Zhou","year":"2018","journal-title":"Curr. Opin. Immunol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.152523_bb0025","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41577-019-0143-6","article-title":"The human antibody response to influenza A virus infection and vaccination","volume":"19","author":"Krammer","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152523_bb0030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/08828245251413233","article-title":"Advances in Mucosal Adjuvants for Influenza Vaccines","volume":"39","author":"Wang","year":"2026","journal-title":"Viral Immunol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2026.152523_bb0035","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2165\/11206860-000000000-00000","article-title":"Live attenuated influenza vaccine (FluMist; Fluenz): a review of its use in the prevention of seasonal influenza in children and adults","volume":"71","author":"Carter","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.ijbiomac.2026.152523_bb0040","doi-asserted-by":"crossref","first-page":"1809302","DOI":"10.3389\/fimmu.2026.1809302","article-title":"Next-generation intranasal influenza vaccines: mechanisms, platforms, and translational progress","volume":"17","author":"Reis","year":"2026","journal-title":"Front Immunol."},{"key":"10.1016\/j.ijbiomac.2026.152523_bb0045","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.3389\/fimmu.2019.01605","article-title":"Innovative mucosal vaccine formulations against influenza A virus infections","volume":"10","author":"Calzas","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2026.152523_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121180","article-title":"Intranasal vaccine: factors to consider in research and development","volume":"609","author":"Xu","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2026.152523_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.808527","article-title":"Potentiating lung mucosal immunity through intranasal vaccination","volume":"12","author":"Nelson","year":"2021","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.152523_bb0060","doi-asserted-by":"crossref","first-page":"2246582","DOI":"10.1080\/22221751.2023.2246582","article-title":"The emergence of new antigen branches of H9N2 avian influenza virus in China due to antigenic drift on hemagglutinin through antibody escape at immunodominant sites","volume":"12","author":"Zhang","year":"2023","journal-title":"Emerg. Microbes Infect."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152523_bb0065","doi-asserted-by":"crossref","first-page":"7603","DOI":"10.1038\/s41467-022-35236-y","article-title":"Structural basis for a human broadly neutralizing influenza A hemagglutinin stem-specific antibody including H17\/18 subtypes","volume":"13","author":"Chen","year":"2022","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.152523_bb0070","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.3390\/v6031294","article-title":"Playing hide and seek: how glycosylation of the influenza virus hemagglutinin can modulate the immune response to infection","volume":"6","author":"Tate","year":"2014","journal-title":"Viruses"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.152523_bb0075","doi-asserted-by":"crossref","first-page":"0021","DOI":"10.1128\/microbiolspec.AID-0021-2014","article-title":"Committing the oldest sins in the newest kind of ways-antibodies targeting the influenza virus type a hemagglutinin globular head","volume":"2","author":"Krause","year":"2014","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.ijbiomac.2026.152523_bb0080","article-title":"Adjuvant-free, self-assembling ferritin nanoparticle vaccine coupled with influenza virus hemagglutinin protein carrying M1 and PADRE epitopes elicits cross-protective immune responses","volume":"16","author":"Zhao","year":"2025","journal-title":"Front. Immunol."},{"issue":"68","key":"10.1016\/j.ijbiomac.2026.152523_bb0085","doi-asserted-by":"crossref","first-page":"63761","DOI":"10.1039\/C6RA12895E","article-title":"PAMAM dendrimer based targeted nano-carrier for bio-imaging and therapeutic agents","volume":"6","author":"Mekuria","year":"2016","journal-title":"RSC Adv."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.152523_bb0090","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1021\/mp3005325","article-title":"Dendrimer nanoscaffolds for potential theranostics of prostate cancer with a focus on radiochemistry","volume":"10","author":"Lo","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijbiomac.2026.152523_bb0095","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.jconrel.2022.10.061","article-title":"Mechanisms and challenges of nanocarriers as non-viral vectors of therapeutic genes for enhanced pulmonary delivery","volume":"352","author":"Wang","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2026.152523_bb0100","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.colsurfb.2019.01.034","article-title":"In silico search, chemical characterization and immunogenic evaluation of amino-terminated G4-PAMAM-HIV peptide complexes using three-dimensional models of the HIV-1 gp120 protein","volume":"177","author":"Rodriguez-Fonseca","year":"2019","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152523_bb0105","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12951-021-00881-w","article-title":"Effects of the surface charge of polyamidoamine dendrimers on cellular exocytosis and the exocytosis mechanism in multidrug-resistant breast cancer cells","volume":"19","author":"Zhang","year":"2021","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152523_bb0110","article-title":"\u03b2-Glucan\u2014a promising immunocyte-targeting drug delivery vehicle: superiority, applications and future prospects","volume":"339","author":"He","year":"2024","journal-title":"Carbohydr. Polym."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.152523_bb0115","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1021\/acs.molpharmaceut.0c00010","article-title":"Conjugation of \u03b2-glucan with the hydrazone and disulfide linkers markedly improves the immunogenicity of Zika virus E protein","volume":"17","author":"Qi","year":"2020","journal-title":"Mol. Pharm."},{"issue":"13","key":"10.1016\/j.ijbiomac.2026.152523_bb0120","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/j.vaccine.2023.01.074","article-title":"Intranasal immunization with curdlan induce Th17 responses and enhance protection against enterovirus 71","volume":"41","author":"Yi","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.ijbiomac.2026.152523_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.858321","article-title":"Alpha-D-glucan-based vaccine adjuvants: current status and future perspectives","volume":"13","author":"Patil","year":"2022","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.152523_bb0130","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3390\/vaccines9080917","article-title":"The promise and challenges of cyclic dinucleotides as molecular adjuvants for vaccine development","volume":"9","author":"Yan","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ijbiomac.2026.152523_bb0135","article-title":"Intranasal immunization with a c-di-GMP-adjuvanted acellular pertussis vaccine provides superior immunity against Bordetella pertussis in a mouse model","volume":"13","author":"Jiang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2026.152523_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.139395","article-title":"A SARS-CoV-2 mucosal nanovaccine based on assembly of maltodextrin, STING agonist and polyethyleneimine","volume":"294","author":"Tian","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152523_bb0145","doi-asserted-by":"crossref","first-page":"6053","DOI":"10.1038\/s41467-024-50234-y","article-title":"An intranasal nanoparticle STING agonist protects against respiratory viruses in animal models","volume":"15","author":"Leekha","year":"2024","journal-title":"Nat. Commun."},{"issue":"30","key":"10.1016\/j.ijbiomac.2026.152523_bb0150","doi-asserted-by":"crossref","first-page":"35895","DOI":"10.1021\/acsami.3c05456","article-title":"Mucosal SARS-CoV-2 nanoparticle vaccine based on mucosal adjuvants and its immune effectiveness by intranasal administration","volume":"15","author":"Xiao","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152523_bb0155","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1021\/acsbiomaterials.3c01247","article-title":"Harnessing nanovaccines for effective immunization-a special concern on COVID-19: facts, fidelity, and future prospective","volume":"10","author":"Gholap","year":"2024","journal-title":"ACS Biomater Sci. Eng."},{"key":"10.1016\/j.ijbiomac.2026.152523_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2021.129392","article-title":"Inhalable nanovaccine with biomimetic coronavirus structure to trigger mucosal immunity of respiratory tract against COVID-19","volume":"418","author":"Zheng","year":"2021","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.ijbiomac.2026.152523_bb0165","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jconrel.2021.02.029","article-title":"A biotin-avidin-system-based virus-mimicking nanovaccine for tumor immunotherapy","volume":"332","author":"Lu","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2026.152523_bb0170","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.4014\/jmb.1805.05053","article-title":"Optimized expression, purification, and rapid detection of recombinant influenza nucleoproteins expressed in Sf9 insect cells","volume":"28","author":"Yoon","year":"2018","journal-title":"J. Microbiol. Biotechnol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.152523_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines11111635","article-title":"Analysing the in-use stability of mRNA-LNP COVID-19 vaccines Comirnaty\u2122 (Pfizer) and Spikevax\u2122 (Moderna): a comparative study of the particulate","volume":"11","author":"Hermosilla","year":"2023","journal-title":"Vaccines"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.152523_bb0180","doi-asserted-by":"crossref","first-page":"586","DOI":"10.4161\/hv.27567","article-title":"Single-dose monomeric HA subunit vaccine generates full protection from influenza challenge","volume":"10","author":"Mallajosyula","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"issue":"37","key":"10.1016\/j.ijbiomac.2026.152523_bb0185","doi-asserted-by":"crossref","first-page":"eadi4753","DOI":"10.1126\/sciadv.adi4753","article-title":"Chimeric hemagglutinin split vaccines elicit broadly cross-reactive antibodies and protection against group 2 influenza viruses in mice","volume":"9","author":"Puente-Massaguer","year":"2023","journal-title":"Sci. Adv."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.152523_bb0190","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/21645515.2020.1780091","article-title":"Characterization of humoral and cellular immune features of gamma-irradiated influenza vaccine","volume":"17","author":"Chen","year":"2021","journal-title":"Hum. Vaccin. Immunother."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.152523_bb0195","doi-asserted-by":"crossref","first-page":"2256422","DOI":"10.1080\/22221751.2023.2256422","article-title":"An mRNA-based broad-spectrum vaccine candidate confers cross-protection against heterosubtypic influenza A viruses","volume":"12","author":"Xiong","year":"2023","journal-title":"Emerg. Microbes Infect."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.152523_bb0200","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.662","article-title":"Immunoglobulin class-switch recombination: mechanism, regulation, and related diseases","volume":"5","author":"Liu","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.ijbiomac.2026.152523_bb0205","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF00276984","article-title":"Optimal strategies in immunology III. The IgM-IgG switch","volume":"10","author":"Perelson","year":"1980","journal-title":"J. Math. Biol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.152523_bb0210","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1089\/vim.2017.0141","article-title":"Influenza virus: dealing with a drifting and shifting pathogen","volume":"31","author":"Kim","year":"2018","journal-title":"Viral Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152523_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.0300-9475.2004.01382.x","article-title":"Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines","volume":"59","author":"Cox","year":"2004","journal-title":"Scand. J. Immunol."},{"issue":"33","key":"10.1016\/j.ijbiomac.2026.152523_bb0220","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1016\/j.vaccine.2021.06.072","article-title":"Universal influenza vaccine based on conserved antigens provides long-term durability of immune responses and durable broad protection against diverse challenge virus strains in mice","volume":"39","author":"Lo","year":"2021","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.152523_bb0225","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.immuni.2022.04.013","article-title":"Mucosal immune responses to infection and vaccination in the respiratory tract","volume":"55","author":"Mettelman","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.ijbiomac.2026.152523_bb0230","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.jconrel.2024.10.031","article-title":"Microparticle and nanoparticle-based influenza vaccines","volume":"376","author":"Ontiveros-Padilla","year":"2024","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.152523_bb0235","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3390\/vaccines8030548","article-title":"Influenza-host interplay and strategies for universal vaccine development","volume":"8","author":"Hwang","year":"2020","journal-title":"Vaccines (Basel)"},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.152523_bb0240","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1016\/j.bbagen.2014.04.023","article-title":"Heteroglucan-dendrimer glycoconjugate: a modulated construct with augmented immune responses and signaling phenomena","volume":"1840","author":"Devi","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"23","key":"10.1016\/j.ijbiomac.2026.152523_bb0245","doi-asserted-by":"crossref","first-page":"23889","DOI":"10.1021\/acsnano.3c08174","article-title":"Manganese dioxide-entrapping dendrimers co-deliver protein and nucleotide for magnetic resonance imaging-guided chemodynamic\/starvation\/immune therapy of tumors","volume":"17","author":"Gao","year":"2023","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.152523_bb0250","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1021\/acsmaterialslett.3c01426","article-title":"Poly(alkylideneamine) dendrimer nanogels codeliver drug and nucleotide to alleviate anticancer drug resistance through immunomodulation","volume":"6","author":"Gao","year":"2024","journal-title":"ACS Mater. Lett."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.152523_bb0255","doi-asserted-by":"crossref","first-page":"4933","DOI":"10.1021\/acs.molpharmaceut.8b00579","article-title":"Acetylated dextran microparticles for codelivery of STING and TLR7\/8 agonists","volume":"15","author":"Collier","year":"2018","journal-title":"Mol. Pharm."},{"issue":"7","key":"10.1016\/j.ijbiomac.2026.152523_bb0260","doi-asserted-by":"crossref","first-page":"7005","DOI":"10.1021\/acsnano.4c14735","article-title":"Multilayer adjuvanted influenza protein nanoparticles improve intranasal delivery and antigen-specific immunity","volume":"19","author":"Park","year":"2025","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.152523_bb0265","doi-asserted-by":"crossref","first-page":"987","DOI":"10.4049\/jimmunol.1002664","article-title":"Seasonal FluMist vaccination induces cross-reactive T cell immunity against H1N1 (2009) influenza and secondary bacterial infections","volume":"186","author":"Sun","year":"2011","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152523_bb0270","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2243","article-title":"Influenza vaccines: past, present, and future","volume":"32","author":"Kim","year":"2022","journal-title":"Rev. Med. Virol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.152523_bb0275","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/irv.12664","article-title":"How to assess the effectiveness of nasal influenza vaccines? Role and measurement of sIgA in mucosal secretions","volume":"13","author":"Gianchecchi","year":"2019","journal-title":"Influenza Other Respi. Viruses"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152523_bb0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085582","article-title":"Comparison of antiviral activity between IgA and IgG specific to influenza virus hemagglutinin: increased potential of IgA for heterosubtypic immunity","volume":"9","author":"Muramatsu","year":"2014","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152523_bb0285","doi-asserted-by":"crossref","first-page":"14912","DOI":"10.1038\/s41598-017-14891-y","article-title":"Efficacy of an adenoviral vectored multivalent centralized influenza vaccine","volume":"7","author":"Lingel","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.152523_bb0290","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12951-025-03122-6","article-title":"Cross-protection against homo and heterologous influenza viruses via intranasal administration of an HA chimeric multiepitope nanoparticle vaccine","volume":"23","author":"Zhao","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"14","key":"10.1016\/j.ijbiomac.2026.152523_bb0295","doi-asserted-by":"crossref","first-page":"13474","DOI":"10.1021\/acsnano.3c01829","article-title":"An intranasal multivalent epitope-based nanoparticle vaccine confers broad protection against divergent influenza viruses","volume":"17","author":"Pan","year":"2023","journal-title":"ACS Nano"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026024505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026024505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T01:09:41Z","timestamp":1783040981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026024505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":59,"alternative-id":["S0141813026024505"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.152523","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanoadjuvant and recombinant hemagglutinin protein-based mucosal influenza nanovaccine confers protection against lethal viral challenge in mice","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.152523","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"152523"}}